Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

BACKGROUND: Guidelines for anal cancer recommend assessment of response at 6–12 weeks after starting treatment. Using data from the ACT II trial, we determined the optimum timepoint to assess clinical tumour response after chemoradiotherapy. METHODS: The previously reported ACT II trial was a phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Glynne-Jones, Robert, Sebag-Montefiore, David, Meadows, Helen M, Cunningham, David, Begum, Rubina, Adab, Fawzi, Benstead, Kim, Harte, Robert J, Stewart, Jill, Beare, Sandy, Hackshaw, Allan, Kadalayil, Latha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337624/
https://www.ncbi.nlm.nih.gov/pubmed/28209296
http://dx.doi.org/10.1016/S1470-2045(17)30071-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337624/
https://www.ncbi.nlm.nih.gov/pubmed/28209296
http://dx.doi.org/10.1016/S1470-2045(17)30071-2

Ejemplares similares